🇺🇸 FDA
Patent

US 8198322

Apoptotic and anti-tumor activities of metallo-salens

granted A61PA61P35/00

Quick answer

US patent 8198322 (Apoptotic and anti-tumor activities of metallo-salens) held by The Board of Regents of the University of Texas System expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jun 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61P, A61P35/00